By way of derogation from the provisions of g of Article D. 1221-61, when labile blood products from several samples are imported with a view to a scheduled autologous transfusion and the planned date of the procedure so requires, the importer may provide only the results of the tests and analyses performed on the first sample.
The import authorisation may be issued on the basis of the results of the tests and analyses performed on this first sample. However, the importer may not make the sampled products available to the health care establishment until he has obtained confirmation that all the results of the tests and analyses comply with the requirements of section 2 of this chapter.